NANS 2020: SPR Therapeutics' Nerve Stimulation System Provides 12-Month Pain Relief After 60-Day Treatment

SPR Therapeutics said its SPRINT neurostimulation technology achieved a 63% reduction in average pain intensity in patients with chronic low back pain.

The peripheral nervous system connects the body to the brain

With the start of the annual American Neuromodulation Society (NANS) tomorrow, SPR Therapeutics Inc. is getting a head-start on announcing encouraging results from a prospective case series of its SPRINT peripheral nerve stimulation (PNS) system.

Results of the study, led by Christopher Gilmore of the Carolinas Pain Institute in Winston Salem, NC, are now published...

More from Clinical Trials

More from R&D